Key result
Higher mPAP is linked to ~10% greater risk of suboptimal response per mmHg after ASD closure.
Why the study?
Clinical responses after transcatheter ASD closure are heterogeneous, and predictors of suboptimal response remain poorly defined.
Do baseline invasive hemodynamic parameters predict suboptimal clinical response in adult patients undergoing percutaneous ASD closure?
Cohort (n=204)
Do baseline invasive hemodynamic parameters predict suboptimal clinical response in adult patients undergoing percutaneous ASD closure?
Higher baseline mean pulmonary artery pressure (mPAP) identifies adult patients at elevated risk for suboptimal clinical response after percutaneous ASD closure.
Answers are grounded in this paper and cite their sources.
Invasive hemodynamics may identify suboptimal responders to ASD closure; leaves open their clinical utility pending prospective validation.
BACKGROUND: Clinical responses after transcatheter atrial septal defect (ASD) closure are heterogeneous, and predictors of suboptimal response remain poorly defined. AIMS: We aimed to determine whether pre-closure invasive hemodynamic parameters might predict clinical response after ASD closure. METHODS: We retrospectively screened 223 consecutive patients undergoing percutaneous secundum ASD closure. After exclusion of 19 patients aged < 18 years, 204 adult patients were included. Clinical response was categorized as improved (n = 66), unchanged (n = 109), or suboptimal (n = 29; defined as persistent or newly apparent dyspnea and/or new initiation of diuretic therapy). Invasive hemodynamic parameters, including pulmonary capillary wedge pressure (PCWP), mean pulmonary artery pressure (mPAP), and pulmonary vascular resistance (PVR), were assessed before closure. RESULTS: Patients with suboptimal clinical response accounted for 14.2% of the adult cohort and had higher baseline mPAP and PCWP than those with improved or unchanged response. Although PVR differed across groups, it was not independently associated with suboptimal response in the multivariable analysis. In the multivariable model, age (OR, 1.05 per year; 95% CI, 1.00-1.09; p = 0.032) and mPAP (OR, 1.10 per mmHg; 95% CI, 1.01-1.20; p = 0.025) were independently associated with suboptimal clinical response, whereas PCWP showed a borderline association. ROC analysis demonstrated moderate discriminative ability of mPAP (AUC, 0.794; 95% CI, 0.698-0.889; p < 0.001). CONCLUSIONS: Baseline invasive hemodynamic burden, particularly mPAP, was associated with suboptimal clinical response and may help identify patients at elevated risk after percutaneous ASD closure.
No takes yet. Share an insight, caveat, or question.
Hashimoto et al. (2026) conducted a cohort in Atrial septal defect (n=204). Baseline mean pulmonary artery pressure (mPAP) was evaluated on Suboptimal clinical response (persistent or newly apparent dyspnea and/or new initiation of diuretic therapy) (OR 1.10, 95% CI 1.01-1.20, p=0.025). Higher baseline mean pulmonary artery pressure was independently associated with a suboptimal clinical response after percutaneous ASD closure (OR 1.10 per mmHg; 95% CI 1.01-1.20; p=0.025).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: